Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carbon

Showing results (11-20 of 332) with videos related to

Pageof 34
Sort By:
Presse Medicale (Paris, France : 1983)|January 22, 1983
[3d-generation cephalosporins in the treatment of purulent meningitis]C Carbon
La Nouvelle Presse Medicale|September 7, 1974
[Septicemias]C Carbon
The Journal of Antimicrobial Chemotherapy|April 1, 1992
Prospective randomized phase II study of intravenous cefpirome 1g or 2g bd in the treatment of hospitalized patients with different infections. Cefpirome Study GroupC Carbon
International Journal of Antimicrobial Agents|November 1, 1993
Pneumonia in the elderlyC Carbon
Clinical Therapeutics|January 1, 1988
Cefaclor therapy for specific upper respiratory tract infections: pharyngitis, purulent rhinitis, laryngotracheitisC Carbon
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Quinupristin/dalfopristin: a review of its activity in experimental animal models of infectionC Carbon
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Ceftazidime on animal experimental models]C Carbon
The Journal of Antimicrobial Chemotherapy|October 8, 1999
Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococciC Carbon
Chemotherapy|September 11, 2001
Comparison of side effects of levofloxacin versus other fluoroquinolonesC Carbon
Medecine Tropicale : Revue Du Corps De Sante Colonial|March 4, 2000
[Antibiotic therapy in developing countries]C Carbon
Pageof 34

Showing results (11-20 of 332) with videos related to

Sort By:
Pageof 34
Presse Medicale (Paris, France : 1983)|January 22, 1983
[3d-generation cephalosporins in the treatment of purulent meningitis]C Carbon
La Nouvelle Presse Medicale|September 7, 1974
[Septicemias]C Carbon
The Journal of Antimicrobial Chemotherapy|April 1, 1992
Prospective randomized phase II study of intravenous cefpirome 1g or 2g bd in the treatment of hospitalized patients with different infections. Cefpirome Study GroupC Carbon
International Journal of Antimicrobial Agents|November 1, 1993
Pneumonia in the elderlyC Carbon
Clinical Therapeutics|January 1, 1988
Cefaclor therapy for specific upper respiratory tract infections: pharyngitis, purulent rhinitis, laryngotracheitisC Carbon
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Quinupristin/dalfopristin: a review of its activity in experimental animal models of infectionC Carbon
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Ceftazidime on animal experimental models]C Carbon
The Journal of Antimicrobial Chemotherapy|October 8, 1999
Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococciC Carbon
Chemotherapy|September 11, 2001
Comparison of side effects of levofloxacin versus other fluoroquinolonesC Carbon
Medecine Tropicale : Revue Du Corps De Sante Colonial|March 4, 2000
[Antibiotic therapy in developing countries]C Carbon
Pageof 34